Acrivon Therapeutics Price Chart
Acrivon Therapeutics Volume Chart
Acrivon Therapeutics Market Segments
Premarket
+0.03(+2.01%)
| Open | $1.49 |
|---|---|
| Close | $1.52 |
| Low | $1.49 |
| Low Change | 0.00 (0.00%) |
| High | $1.59 |
| High Change | +0.10 (+6.71%) |
| Range | $0.10 |
| Volume | 5.354K |
| Dollar Volume | $8.14K |
After Hours Yesterday
+0.03(+1.94%)
| Open | $1.55 |
|---|---|
| Close | $1.58 |
| Low | $1.55 |
| Low Change | 0.00 (0.00%) |
| High | $1.58 |
| High Change | +0.03 (+1.94%) |
| Range | $0.03 |
| Volume | 7.129K |
| Dollar Volume | $11.26K |
Regular Trading Hours Yesterday
+0.03(+1.99%)
| Open | $1.51 |
|---|---|
| Close | $1.54 |
| Low | $1.51 |
| Low Change | 0.00 (0.00%) |
| High | $1.58 |
| High Change | +0.07 (+4.64%) |
| Range | $0.07 |
| Volume | 230.848K |
| Dollar Volume | $355.51K |
Premarket Yesterday
+0.00(+0.00%)
| Open | $1.51 |
|---|---|
| Close | $1.51 |
| Low | $1.46 |
| Low Change | -0.05 (-3.31%) |
| High | $1.51 |
| High Change | +0.00 (+0.00%) |
| Range | $0.05 |
| Volume | 13.749K |
| Dollar Volume | $20.76K |
Acrivon Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.56 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.64 |
| 20 Day Moving Average (SMA20) | $1.74 |
| 50 Day Moving Average (SMA50) | $1.73 |
| 100 Day Moving Average (SMA100) | $1.72 |
| 200 Day Moving Average (SMA200) | $1.85 |
Acrivon Therapeutics Statistics
| Average Volume (30 Days) | 696.57K |
|---|---|
| P/E Ratio (Current) | -.83 |
| EPS (Current) | -$1.81 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$66.29M |
| Cash Ratio | 3.08 |
| Current Ratio | 8.98 |
| Quick Ratio | 8.98 |
| Debt to Equity | 0.00 |
| Enterprise Value | $30.57M |
| EV to EBITDA | -0.38 |
| EV to Sales | — |
| Price to Book | 0.68 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.72% |
| Return on Equity | -0.81% |
Acrivon Therapeutics Stock Splits
There have been no stock splits for Acrivon Therapeutics (ACRV).
Acrivon Therapeutics Dividends
There have been no dividends for Acrivon Therapeutics (ACRV).